Bacilloscopy for leprosy in Brazil's public health system between 2013 and 2022

Main Article Content

Ricardo Barbosa-Lima
https://orcid.org/0000-0001-5274-4800
Geissiane Felizardo Vivian
Lincoln Max Rocha Alba
https://orcid.org/0000-0001-5732-3036
Kaisa Silva Nascimento de Gois
https://orcid.org/0000-0003-2881-3161
Vivian Aparecida Tomaz
https://orcid.org/0000-0001-5359-1404
Murilo Correzola Pinto
https://orcid.org/0000-0003-1691-0538
Flávia Freire Ramos-Silva
https://orcid.org/0000-0003-2010-5216
Glebson Moura Silva
https://orcid.org/0000-0002-4977-2787

Abstract

Objective: To evaluate the annual number of skin smear microscopies for leprosy performed in the Unified Health System (SUS) in the last decade. Methods: An ecological, longitudinal, retrospective, and quantitative study was conducted using data from the Ambulatory Information System (SIA/SUS). The number of skin smear microscopies for leprosy per 100,000 residents was estimated for Brazil and its five macroregions, between 2013 and 2022, with a significance level (a) of 5%. Results: More than 1.3 million skin smear microscopies were reported in the last decade in the SUS. The median annual incidence was 67 skin smear microscopies for leprosy per 100,000 residents, with the maximum observed in 2013 (82) and the minimum in 2022 (46). Annual incidences in the North, Central-West, and Northeast macro-regions were significantly higher than the national estimate, whereas in the South and Southeast, they were lower (p <0.05). The temporal trend was considered decreasing for the national estimate (p = 0.002), with an annual percentage variation of -5.6% (95%CI = -3.8%; -8.2%). However, after disregarding the years of the COVID-19 pandemic (2020-2022), the trend became stationary (p = 0.181). Furthermore, the incidence during the pre-pandemic period was significantly higher compared with the third year after the advent of the pandemic in all macro-regions of Brazil (<0.05). Conclusion: It was possible to conclude that the SUS performed a significant number of skin smear microscopies for leprosy in the last ten years, but there are macro-regional disparities in Brazil and a significant impact of the COVID-19 pandemic.



Article Details

How to Cite
1.
Barbosa-Lima R, Vivian GF, Alba LMR, de Gois KSN, Tomaz VA, Pinto MC, et al. Bacilloscopy for leprosy in Brazil’s public health system between 2013 and 2022. HSJ [Internet]. 2023 Dec. 28 [cited 2024 Dec. 28];13(4):38-45. Available from: https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1458
Section
ORIGINAL ARTICLE
Author Biographies

Ricardo Barbosa-Lima, Metropolitan Faculty of the State of São Paulo (FAMEESP)

Dental surgeon, Public Health Specialist.

Geissiane Felizardo Vivian, Federal University of Sergipe (UFS)

Physician

Lincoln Max Rocha Alba, Federal University of Sergipe (UFS)

Medical Student

Kaisa Silva Nascimento de Gois, Federal University of Sergipe (UFS)

Physician

Murilo Correzola Pinto, Federal University of Sergipe (UFS)

Medical Student

Flávia Freire Ramos-Silva, State Department of Health of Pernambuco, Petrolina, PE.

Nurse, Master in Public Health Policy.

Glebson Moura Silva, Federal University of Sergipe (UFS)

Nurse, PhD in Education.

References

Chen KH, Lin CY, Su SB, Chen KT. Leprosy: a review of epidemiology, clinical diagnosis, and management. J Trop Med. 2022;2022:8652062. https://doi.org/10.1155/2022/8652062 DOI: https://doi.org/10.1155/2022/8652062

PMid:35832335 PMCid:PMC9273393

Froes-Junior LAR, Sotto MN, Trindade MAB. Leprosy: clinical and immunopathological characteristics. An Bras Dermatol. 2022;97(3):338-47. https://doi.org/10.1016/j.abd.2021.08.006 PMid:35379512 PMCid:PMC9133310 DOI: https://doi.org/10.1016/j.abd.2021.08.006

Gilmore A, Roller J, Dyer JA. Leprosy (Hansen's disease): an update and review. Mo Med. 2023;120(1):39-44. PMid:36860602 PMCid:PMC9970335

Makhakhe L. Leprosy review. S Afr Fam Pract (2004). 2021;63(1):e1-6. https://doi.org/10.4102/safp.v63i1.5311 PMid:34797098 PMCid:PMC8603093 DOI: https://doi.org/10.4102/safp.v63i1.5311

Santos MASD, Mercadante LM, Pegas ES, Kadunc BV. Relationship between bacilloscopy and operational classification of Hansen's disease in patients with reactions. An Bras Dermatol. 2018;93(3):454-6https://doi.org/10.1590/abd1806-4841.20186725 PMid:29924247 PMCid:PMC6001107 DOI: https://doi.org/10.1590/abd1806-4841.20186725

Belotti NCU, Nardi SMT, Paschoal VDA, Montanha JOM, Pedro HSP, Gazetta CE. Laboratory diagnosis of leprosy: two staining methods from bacilloscopy and rapid ml flow test. Int J Mycobacteriol. 2021;10(4):393-7. https://doi.org/10.4103/ijmy.ijmy_206_21 PMid:34916457 DOI: https://doi.org/10.4103/ijmy.ijmy_206_21

Lima LV, Pavinati G, Silva IGP, Moura DRO, Gil NLM, Magnabosco GT. Temporal trend, distribution and spatial autocorrelation of leprosy in Brazil: ecological study, 2011 to 2021. Rev Bras Epidemiol. 2022;25:e220040. https://doi.org/10.1590/1980-549720220040 PMid:36478213

Miguel CB, Mota PB, Afonso BO, Agostinho F, Cazzaniga RA, Abreu MCM, et al. Leprosy morbidity and mortality in Brazil: 2008-2018. Braz J Infect Dis. 2021;25(6):101638. https://doi.org/10.1016/j.bjid.2021.101638 PMid:34756836 PMCid:PMC9392197 DOI: https://doi.org/10.1016/j.bjid.2021.101638

Barbosa-Lima R, Ramos-Silva FF, Santos JCO, Santos DKC, Silva GM, Kameo SY. Leprosy bacilloscopy notifications in the Brazilian Unified Health System and COVID-19 pandemic: an ecological investigation. J Health Biol Sci. 2023 [cited 2023 Dec 14];11(1):1-5. Available from: https://periodicos.unichristus.edu.br/jhbs/article/view/4656 DOI: https://doi.org/10.12662/2317-3076jhbs.v11i1.4656.p1-5.2023

Marques NP, Marques NCT, Cardozo IM, Martelli DRB, Lucena EG, Oliveira EA, et al. Impact of the coronavirus disease 2019 on the diagnoses of Hansen's disease in Brazil. Rev Soc Bras Med Trop. 2021;54:e02512021. https://doi.org/10.1590/0037-8682-0251-2021 PMid:34320132 PMCid:PMC8313100 DOI: https://doi.org/10.1590/0037-8682-0251-2021

Deps P, Collin SM, Andrade VLG. Hansen's disease case detection in Brazil: a backlog of undiagnosed cases due to COVID-19 pandemic. J Eur Acad Dermatol Venereol. 2022;36(10):e754-5. https://doi.org/10.1111/jdv.18307 PMid:35680545 PMCid:PMC9347646 DOI: https://doi.org/10.1111/jdv.18307

Merchán-Hamann E, Tauil PL. Proposal for classifying the different types of descriptive epidemiological studies. Epidemiol Serv Saude. 2021;30(1): e2018126. https://doi.org/10.1590/s1679-49742021000100026 PMid:33950133 DOI: https://doi.org/10.1590/s1679-49742021000100026

Malta M, Cardoso LO, Bastos FI, Magnanini MM, Silva CM. STROBE initiative: guidelines on reporting observational studies. Rev Saude Publica. 2010;44(3):559-65. https://doi.org/10.1590/S0034-89102010000300021 PMid:20549022 DOI: https://doi.org/10.1590/S0034-89102010000300021

Brasil, Ministério da Saúde. Departamento de Informática - Sistema Único de Saúde (DATASUS) [Internet]. Brasília (DF): Ministério da Saúde; 2023 [cited 2023 Jul 6]. Available from: https://datasus.saude.gov.br/

Brasil, Instituto Brasileiro de Geografia e Estatística [Internet]. Brasília (DF): Instituto Brasileiro de Geografia e Estatística; 2023 [cited 2023 Jul 7]. Available from: http://www.ibge.gov.br/

Pagano M, Gauvreau K, Heather M. Principles of bioestatistics. 3a. ed. Boca Raton: CRC Press; 2022. 620p.

Latorre MRDO, Cardoso MRA. Time series analysis in epidemiology: an introduction to methodological aspects. Rev Bras Epidemiol. 2001;4(3):145-52. https://doi.org/10.1590/S1415-790X2001000300002 DOI: https://doi.org/10.1590/S1415-790X2001000300002

Antunes JLF, Cardoso MRA. Using time series analysis in epidemiological studies. Epidemiol Serv Saude. 2015;24(3):565-76. https://doi.org/10.5123/S1679-49742015000300024 DOI: https://doi.org/10.5123/S1679-49742015000300024

Brasil, Ministério da Saúde. Resolução n. 510 de 7 de abril de 2016 [Internet]. Dispõe sobre as normas aplicáveis a pesquisas em ciências humanas e sociais. Diário Oficial da União. 2016 mai. 24; Seção 1. p 44.

Martins-Melo FR, Assunção-Ramos AV, Ramos Júnior AN, Alencar CH, Montenegro Júnior RM, Oliveira MLW, et al. Leprosy-related mortality in Brazil: a neglected condition of a neglected disease. Trans R Soc Trop Med Hyg. 2015;109(10):643-52. https://doi.org/10.1093/trstmh/trv069 PMid:26354792 DOI: https://doi.org/10.1093/trstmh/trv069

Silva CLM, Fonseca SC, Kawa H, Palmer DOQ. Spatial distribution of leprosy in Brazil: a literature review. Rev Soc Bras Med Trop. 2017;50(4):439-49. https://doi.org/10.1590/0037-8682-0170-2016 PMid:28954063 DOI: https://doi.org/10.1590/0037-8682-0170-2016

Pescarini JM, Strina A, Nery JS, Skalinski LM, Andrade KVF, Penna MLF, et al. Socioeconomic risk markers of leprosy in high-burden countries: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2018;12(7):e0006622. https://doi.org/10.1371/journal.pntd.0006622 PMid:29985930 PMCid:PMC6053250 DOI: https://doi.org/10.1371/journal.pntd.0006622

Lima LV, Pavinati G, Silva IGP, Moura DRO, Gil NL, Magnabosco GT. Temporal trend, distribution and spatial autocorrelation of leprosy in Brazil: ecological study, 2011 to 2021. Rev Bras Epidemiol. 2022;25:e220040. https://doi.org/10.1590/1980-549720220040.2 DOI: https://doi.org/10.1590/1980-549720220040

Brasil, Ministério da Saúde. Protocolo Clínico e Diretrizes Terapêuticas da Hanseníase [Internet]. Brasília: Secretaria de Vigilância em Saúde, Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis; 2022 [citado 7 jul 2023]. Available from: https://bit.ly/3GIT19k

Diniz SPMC, Pereira DLM, Aquino DMC, Oliveira BLCA, Rabelo PPC, Rolim ILTP. Impacto da COVID-19 na assistência às pessoas acometidas pela hanseníase. Rev Enferm Atual In Derme. 2023;97(2):e023078. https://doi.org/10.31011/reaid-2023-v.97-n.2-art.1627 DOI: https://doi.org/10.31011/reaid-2023-v.97-n.2-art.1627

Lopes JGCBS, Silva IM, Leal MGC, Ribeiro AMS, Leitão JCU, Sousa AFDS, et al. Subdiagnóstico de hanseníase no Brasil durante a pandemia da COVID-19. REAMed. 2022;20:e11172. https://doi.org/10.25248/reamed.e11172.2022 DOI: https://doi.org/10.25248/reamed.e11172.2022

Reis ACNF, Oliveira JPM, Gomes HS, Cavalcante NV. Impact of the COVID-19 pandemic on the continued care of leprosy: an integrative review. RSD. 2022;11(14):e339111436490. https://doi.org/10.33448/rsd-v11i14.36490 DOI: https://doi.org/10.33448/rsd-v11i14.36490

Mendonça IMS, Eleres FB, Silva EMS, Ferreira SMB, Sousa GS. Impact of the COVID-19 pandemic on the care of patients with leprosy: an evaluative study from the perspective of the health professional. RSD. 2022;11(2):e4111225459.

Most read articles by the same author(s)